Stocks and Investing Stocks and Investing
Wed, February 14, 2024

Shagun Singh Reiterated (ABT) at Buy and Held Target at $128 on, Feb 14th, 2024


Published on 2024-10-28 08:57:15 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Reiterated "Abbott Laboratories" (ABT) at Buy and Held Target at $128 on, Feb 14th, 2024.

Shagun has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 1 agrees with Shagun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $107 on, Thursday, October 19th, 2023


These are the ratings of the 4 analyists that currently disagree with Shagun


  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $141 on, Friday, January 26th, 2024
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $127 on, Thursday, January 25th, 2024
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $126 on, Thursday, January 25th, 2024
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $121 on, Wednesday, December 13th, 2023
Contributing Sources